Courts may restrict access to the popular abortion medication mifepristone in the United States. Telehealth providers have backup plans in place.

Pharmaceutical giant Eli Lilly alleges the companies are selling illegal off-brand versions of its best-selling diabetes and weight-loss drugs, Mounjaro and Zepbound.

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.